The holy grail of treatment for people with Type 1 diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 8, 2015-08 ,pp. : 983-983

John Wiley & Sons Inc

Access to resources Recommend Favorite

Compliance with drug therapy for postmenopausal osteoporosis

By Weycker D.   Macarios D.   Edelsberg J.   Oster G.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1645-1652

Springer Publishing Company

Access to resources Recommend Favorite

Nuclear Factor-&kgr;B: A Holy Grail in Cancer Prevention and Therapy

By  

Current Signal Transduction Therapy, Vol. 1, Iss. 1, 2006-01 ,pp. : 25-52

Bentham Science Publishers

Access to resources Recommend Favorite

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

By Sebba Anthony I.   Bonnick Sydney Lou   Kagan Risa   Thompson Desmond E.   Skalky Carol S.   Chen Erluo   de Papp Anne E.    

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2031-2041

Informa Healthcare

Access to resources Recommend Favorite

Sequential therapy in the treatment of osteoporosis

By Boonen Steven   Milisen Koen   Gielen Evelien   Vanderschueren Dirk  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1149-1155

Informa Healthcare

Access to resources Recommend Favorite